» Articles » PMID: 38771640

Molecular and Cellular Context Influences SCN8A Variant Function

Abstract

Pathogenic variants in SCN8A, which encodes the voltage-gated sodium (NaV) channel NaV1.6, associate with neurodevelopmental disorders, including developmental and epileptic encephalopathy. Previous approaches to determine SCN8A variant function may be confounded by use of a neonatally expressed, alternatively spliced isoform of NaV1.6 (NaV1.6N) and engineered mutations rendering the channel tetrodotoxin (TTX) resistant. We investigated the impact of SCN8A alternative splicing on variant function by comparing the functional attributes of 15 variants expressed in 2 developmentally regulated splice isoforms (NaV1.6N, NaV1.6A). We employed automated patch clamp recording to enhance throughput, and developed a neuronal cell line (ND7/LoNav) with low levels of endogenous NaV current to obviate the need for TTX-resistance mutations. Expression of NaV1.6N or NaV1.6A in ND7/LoNav cells generated NaV currents with small, but significant, differences in voltage dependence of activation and inactivation. TTX-resistant versions of both isoforms exhibited significant functional differences compared with the corresponding WT channels. We demonstrated that many of the 15 disease-associated variants studied exhibited isoform-dependent functional effects, and that many of the studied SCN8A variants exhibited functional properties that were not easily classified as either gain- or loss-of-function. Our work illustrates the value of considering molecular and cellular context when investigating SCN8A variants.

Citing Articles

Nociceptor sodium channels shape subthreshold phase, upstroke, and shoulder of action potentials.

Koster P, Leipold E, Tigerholm J, Maxion A, Namer B, Stiehl T J Gen Physiol. 2025; 157(2.

PMID: 39836077 PMC: 11748974. DOI: 10.1085/jgp.202313526.


The Need for Speed; Investigating Channelopathy-Associated Epilepsy Using High Throughput Electrophysiological Approaches.

George Jr A, Kiskinis E Epilepsy Curr. 2024; 24(5):345-349.

PMID: 39508013 PMC: 11536426. DOI: 10.1177/15357597241280484.


Protein isoform-centric therapeutics: expanding targets and increasing specificity.

Kjer-Hansen P, Phan T, Weatheritt R Nat Rev Drug Discov. 2024; 23(10):759-779.

PMID: 39232238 DOI: 10.1038/s41573-024-01025-z.


Allele-Specific Editing of a Dominant SCN8A Epilepsy Variant Protects against Seizures and Lethality in a Murine Model.

Yu W, Hill S, Huang Y, Zhu L, Demetriou Y, Ziobro J Ann Neurol. 2024; 96(5):958-969.

PMID: 39158034 PMC: 11496010. DOI: 10.1002/ana.27053.

References
1.
Jiang C, Richardson E, Farr J, Hill A, Ullah R, Kroncke B . A calibrated functional patch-clamp assay to enhance clinical variant interpretation in KCNH2-related long QT syndrome. Am J Hum Genet. 2022; 109(7):1199-1207. PMC: 9300752. DOI: 10.1016/j.ajhg.2022.05.002. View

2.
Quinn S, Zhang N, Fenton T, Brusel M, Muruganandam P, Peleg Y . Complex biophysical changes and reduced neuronal firing in an SCN8A variant associated with developmental delay and epilepsy. Biochim Biophys Acta Mol Basis Dis. 2024; 1870(5):167127. DOI: 10.1016/j.bbadis.2024.167127. View

3.
Copley R . Evolutionary convergence of alternative splicing in ion channels. Trends Genet. 2004; 20(4):171-6. DOI: 10.1016/j.tig.2004.02.001. View

4.
Liang L, Fazel Darbandi S, Pochareddy S, Gulden F, Gilson M, Sheppard B . Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain. Genome Med. 2021; 13(1):135. PMC: 8383430. DOI: 10.1186/s13073-021-00949-0. View

5.
Sergeeva O, Shcherbinina E, Shomron N, Zatsepin T . Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications. Nucleic Acid Ther. 2022; 32(3):123-138. DOI: 10.1089/nat.2021.0067. View